John Paulson’s portfolio: Paulson & Co 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001035674Latest: Q2 2026

Q1 2026 filing in brief

In its Q1 2026 13F, filed May 15, 2026, Paulson & Co reported $3.1B across 9 US positions. The largest: PPTA (29.2%), MDGL (23.4%), AAMI (13.5%), BHC (12.7%), NG (7.9%). In the quarter it opened 1 position, sold out of 1, added to 2 and trimmed 1; positions opened and sold out came to 2.1% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed May 15, 2026

  • 1 New
  • 2 Added
  • 1 Trimmed
  • 1 Exited

9 positions at March 31, 2026. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1PPTAPERPETUA RESOURCES CORP$910M32.3M29.23%0.0%Held
2MDGLMADRIGAL PHARMACEUTICALS INC$729M1.4M23.42%−18.5%Trimmed
3AAMIACADIAN ASSET MANAGEMENT INC$421M7.7M13.54%0.0%Held
4BHCBAUSCH HEALTH COS INC$396M73.3M12.71%0.0%Held
5NGNOVAGOLD RESOURCES INC$245M27.2M7.86%0.0%Held
6THMINTERNATIONAL TOWER HILL MIN$229M99.6M7.36%+41.8%Added
7AEMAGNICO EAGLE MINES LTD$159M783.6K5.11%0.0%Held
8THRYTHRYV HLDGS INC$23M8.4M0.74%+94.2%Added
9AM6AMICUS THERAPEUTIC$469K32.4K0.02%—New
1 exited position

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
SOLSSOLSTICE ADVANCED MATLS INC$68M1.4M
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.